Finance

Beta
Lists
SYNACT:STO
SynAct Pharma AB
SEK 13.82
-0.72%
(-0.10) 1D
Jun 3, 5:29:48 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for SYNACT...
Open
SEK 14.08
High
SEK 14.38
Low
SEK 13.74
Mkt. cap
737.02M
Avg. vol.
373.77K
Volume
306.42K
52-wk high
SEK 25.30
52-wk low
SEK 12.82
EPS
-SEK 2.14
Shares outstanding
53.33M
No. of employees
8
Open
SEK 14.08
High
SEK 14.38
Low
SEK 13.74
Mkt. cap
737.02M
Avg. vol.
373.77K
Volume
306.42K
52-wk high
SEK 25.30
52-wk low
SEK 12.82
EPS
-SEK 2.14
Shares outstanding
53.33M
No. of employees
8
News stories
From sources across the web
About SynAct Pharma AB
CEOJeppe Øvlesen
Employees8
FoundedMar 14, 2012
Headquarters-
SectorBiotechnology
Websitesynactpharma.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
23.71M
28.12M
12.32M
22.87M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.69M
7.77M
10.45M
7.71M
Operating expense
30.34M
35.38M
22.47M
30.56M
Total operating expenses
30.34M
35.38M
22.47M
30.56M
Operating income
-30.34M
-35.38M
-22.47M
-30.56M
Other non operating income
1.00K
-
-
14.00K
EBT including unusual items
-30.06M
-35.71M
-22.90M
-30.54M
EBT excluding unusual items
-30.06M
-35.71M
-22.90M
-30.54M
Income tax expense
-2.53M
-16.00K
27.00K
-5.06M
Effective tax rate
8.43%
0.04%
-0.12%
16.56%
Other operating expenses
-53.00K
-511.00K
-298.00K
-23.00K
Net income
-27.52M
-35.69M
-22.93M
-25.49M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
288.00K
-
2.13M
-
Interest expense
-
-330.00K
-
-
Net interest expenses
288.00K
-330.00K
2.13M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-22.47M
-30.55M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer